Products Explained

Peritoneal Dialysis (PD) products

The information contained in this page is intended for U.S. healthcare professionals only.

Baxter has long been committed to developing dialysis systems and solutions to enhance therapy outcomes for a wide range of patients with a wide range of needs. These include:

PD Dialysis Solutions

Baxter offers multiple dialysis solutions to help make the most of your patients' Peritoneal Dialysis (PD) therapy so you can prescribe the solution that best meets your patients' specific medical needs.

Dianeal solution

Dianeal solution

The first commercial Continuous Ambulatory Peritoneal Dialysis (CAPD) solution, Dianeal solution continues to offer reliable results for dialysis patients based on 30 years' trusted experience.

Read More
EXTRANEAL(icodextrin) Solution

Extraneal (icodextrin) Solution

Appropriate for patients who have fluid management challenges to improve long dwell ultrafiltration

Click here for full prescribing information, important risk information and the Medication Guide on Extraneal solution.

Read More

Dialysis Delivery Systems

Baxter provides delivery systems you can count on for both Automated Peritoneal Dialysis (APD) and Continuous Ambulatory Peritoneal Dialysis (CAPD) therapy, including:


Ultrabag System

A proven Continuous Ambulatory Peritoneal Dialysis (CAPD) delivery system that helps minimize the potential for touch contamination.

Read More
HomeChoice & HomeChoice Pro

HomeChoice & HomeChoice Pro APD system

A simple, portable cycler (available with or without a data card reader), that is designed to meet your patient's individual needs for Automated Peritoneal Dialysis (APD) therapy.

Read More


PD LINK (version 3.0)

PD LINK Software

An easy-to-use, Windows®-based software that helps you track and adjust your patient's dialysis therapy.

Read More
PD Adequest 2.0 Software

PD Adequest 2.0 Software

PD Adequest 2.0 is a powerful, Windows-based tool created to measure, report, and predict the adequacy of PD prescriptions for individual patients.

Read More